IFNG and neoplasm: This study demonstrates for the first time that the synthetic triterpenoid CDDO-Me markedly attenuates the immunosuppressive activation state of primary breast TAMs, inhibiting both RNA and protein expression of tumor-promoting IL-10 and VEGF, while enhancing expression of immune-stimulatory TNF-α, IFN-γ, and IL-6.